In comparison with the control group, the incidence of grade 3 or 4 thrombocytopenia in the experimental group was lower, suggesting that TPO-RAs helped prevent the occurrence of severe thrombocytopenia. The gene discussed is TPO; the disease is Thrombocytopenia.